Triadermex

Triadermex is an FDA-registered drug product whose active ingredient is TRIAMCINOLONE ACETONIDE. It is labelled by Florrax Pharmaceutical and marketed as a human prescription drug product. Identifiers on file: NDC 84460-100, label effective 20260806. It is one of 91 FDA drug label records sharing the active ingredient TRIAMCINOLONE ACETONIDE. This page reproduces the FDA-approved label text so you can check what a product is, who makes it and how it is supplied before discussing it with a pharmacist or prescriber.

Across FDA labelling, products containing TRIAMCINOLONE ACETONIDE are most often described in connection with: indications usage, topical corticosteroids, pruritic manifestations, corticosteroid-responsive dermatoses. Wording differs between labels, and the full indications section on this page takes precedence when it is present.

INDICATIONS & USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

DOSAGE & ADMINISTRATION Topical corticosteroids are generally applied to the affected area as a thin film two to four times daily for the 0.025% strength and two or three times daily for the 0.1% and 0.5% strength depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.

CONTRAINDICATIONS Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria.

FDA lists 91 drug label records with TRIAMCINOLONE ACETONIDE as the active ingredient. The most common dosage forms and the manufacturers with the most records are summarised below; strengths, pack sizes and inactive ingredients can still differ between apparently similar products.

What is Triadermex used for?
INDICATIONS & USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Who makes Triadermex?
Florrax Pharmaceutical is the labeler of record for Triadermex. 91 FDA label records share the active ingredient TRIAMCINOLONE ACETONIDE, so generic and branded versions may come from different companies; the manufacturer named on your pack is the one that matters for any enquiry.

Is Triadermex prescription or over-the-counter?
The FDA label for this product is recorded as human prescription drug. Marketing status can differ between strengths and countries, so check the dispensing rules where you live.

Are there other products containing TRIAMCINOLONE ACETONIDE?
Yes. 91 FDA drug label records list TRIAMCINOLONE ACETONIDE as the active ingredient. Products with the same active ingredient can usually be substituted only when a prescriber or pharmacist confirms it is appropriate.

Has Triadermex been recalled?
No FDA recall record in our database matches this product name or manufacturer. Recall data is updated periodically, so a very recent notice may not appear here yet.

Where does this information come from?
All content is reproduced from FDA Structured Product Labelling data via openFDA. It is provided for identification and reference only and is not medical advice.